EWTX - Spark Newswire

7 minute read

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO

August 5, 8:04 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4)

ABSI

2 minute read

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

July 21, 12:33 PM

CEMI

7 minute read

The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street

By Shanthi Rexaline

July 20, 8:19 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19)

ABIO

20 minute read

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

July 19, 10:04 AM

Stocks That Hit 52-Week Lows On Monday Monday morning, 285 companies reached new 52-week lows.

AAU

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

July 7, 12:36 PM

Gainers

ADXS

4 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

July 2, 11:11 AM

Before 10 a.m. ET on Friday, 43 companies set new 52-week lows.

ACXP

4 minute read

The Daily Biotech Pulse: Iterum’s Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures

By Shanthi Rexaline

July 2, 7:38 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 1)

ALXN

5 minute read

Uncategorized

The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts

By Shanthi Rexaline

May 14, 7:59 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13)

ACHL

1 minute read

Uncategorized

Edgewise Therapeutics Q1 EPS $(0.14)

By Benzinga Newsdesk

May 13, 4:43 PM

Edgewise Therapeutics (NASDAQ:EWTX) reported quarterly losses of $(0.14) per share.

EWTX

1 minute read

Uncategorized

SVB Leerink Initiates Coverage On Edgewise Therapeutics with Outperform Rating, Announces Price Target of $34

By Benzinga Newsdesk

April 20, 7:53 AM

SVB Leerink analyst Joseph Schwartz initiates coverage on Edgewise Therapeutics (NASDAQ:EWTX) with a Outperform rating and announces Price Target of $34.

EWTX

Feed Symbols: EWTX